General description
INN
Linezolid
ATC codes
Medicine type
Chemical agent
Antibiotic groups
EML status history
First added in 2015
(TRS
994)
for
Multi-drug resistant Mycobacterium tuberculosis
Added in 2017
(TRS
1006)
for
Other specified bacterial diseases
Added in 2019
(TRS
1021)
for
Vancomycin resistant Enterococcus
Added in 2019
(TRS
1021)
for
Vancomycin resistant Staphylococcus aureus
Added in 2019
(TRS
1021)
for
Methicillin resistant Staphylococcus aureus
Removed in 2019
(TRS
1021)
for
Other specified bacterial diseases
Wikipedia
DrugBank
Recommendations
Section
Reserve group antibiotics
- Parenteral > General injections > IV: 2 mg per mL in 300 mL bag
- Oral > Liquid: 100 mg per 5 mL powder for oral liquid
- Oral > Solid: 400 mg tablet; 600 mg tablet
- Oral > Solid > dispersible tablet: 150 mg
- Oral > Solid > tablet: 600 mg
Section
Antituberculosis medicines
- Oral > Solid > dispersible tablet: 150 mg
- Oral > Solid > tablet: 600 mg
Indications